NASDAQ: VCYTVeracyte Inc Stock Ownership - Who owns Veracyte?
Insider buying vs selling
Have Veracyte Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jonathan Wygant | CAO;VP | 2026-10-28 | 1,306 | $50.31 | $65.70kSell |
| Karin Eastham | Director | 2026-10-27 | 14,850 | $50.01 | $742.57kSell |
| Jens Holstein | Director | 2026-10-27 | 7,500 | $50.00 | $375.00kSell |
| Jens Holstein | Director | 2026-10-27 | 7,500 | $35.30 | $264.75kBuy |
| Karin Eastham | Director | 2026-10-27 | 10,000 | $27.01 | $270.10kBuy |
| Muna Bhanji | Director | 2026-10-19 | 1,864 | $43.70 | $81.46kSell |
| Jens Holstein | Director | 2026-09-24 | 7,500 | $35.30 | $264.75kBuy |
| Jens Holstein | Director | 2026-09-24 | 7,500 | $47.00 | $352.50kSell |
| John Leite | CCO | 2026-09-21 | 4,015 | $40.00 | $160.60kSell |
| Jens Holstein | Director | 2026-09-14 | 5,000 | $40.95 | $204.75kSell |
VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VCYT insiders and whales buy or sell their stock.
VCYT Shareholders
What type of owners hold Veracyte Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brian G. Atwood | 4.50% | 3,616,221 | $177.19M | Insider |
| Samuel D. Colella | 4.50% | 3,616,221 | $177.19M | Insider |
| Versant Ventures III LLC | 4.50% | 3,616,221 | $177.19M | Insider |
| Tpg Group Holdings Sbs Advisors Inc | 4.42% | 3,551,929 | $174.04M | Insider |
| Brook H. Byers | 4.42% | 3,551,929 | $174.04M | Insider |
| Nicole Vitullo | 3.84% | 3,086,024 | $151.22M | Insider |
| Kathleen K. Schoemaker | 3.84% | 3,086,024 | $151.22M | Insider |
| Brian H. Dovey | 3.84% | 3,086,024 | $151.22M | Insider |
| James C. Blair | 3.84% | 3,086,024 | $151.22M | Insider |
| Brian K. Halak | 3.84% | 3,086,024 | $151.22M | Insider |
VCYT vs Biotech Stocks
Veracyte Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.